Send page as link
Print page
| |||||
Portal for sundhedspersoner
Research and development
| Danmark | ||
  |
| |
 |
|
| Research into new drugs is crucial for both patients and Boehringer Ingelheim. Internationally, the company spent 1.6 billion Euros on research and development in 2006. This was 16 % more than the previous year, and corresponds to approximately 18% of the sale of prescription medicine. Boehringer Ingelheim in Denmark also contributes to the corporation’s research and development. In 2006, we took part in 16 international clinical trials involving the monitoring of almost 1,700 patients. | |
  | |
© 2010 Boehringer Ingelheim Danmark A/S.
All rights reserved. Terms of use. |
 |
|
5. September 2010 |
